Abstract
One-third of Americans between age 50 and 75 years are not up to date with colorectal cancer (CRC) screening. Barriers to colonoscopy and stool-based testing have led to ongoing interest in blood-based screening tests. As part of a clinical trial assessing the impact of offering a Septin9 blood test for CRC screening in individuals who’ve previously declined colonoscopy and fecal immunochemical testing (FIT), we conducted a questionnaire to understand patient perspectives on different CRC screening methods.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
